Covid-19: Johnson & Johnson's vaccine 66% effective in large global trial
In the trial of nearly 44,000 volunteers, the level of protection against moderate and severe COVID-19 varied from 72 per cent in the United States
Full Article
Covid-19: Johnson & Johnson's vaccine 66% effective in large global trial
Khaleej Times
0 shares
1 views
You might like
Related news coverage
Study: J&J COVID-19 Vaccine 72% Effective in U.S.
Newsy
Watch VideoAnother drugmaker is sharing the data that their COVID vaccine works. In clinical trials of more than 43,000 people,..
-
J&J vaccine adds to COVID-19 armoury, includes South African variant
Upworthy
-
News24.com | LIVE | J&J Covid-19 vaccine is 72% effective in the US, and 66% overall in large trial
News24
-
Single-shot Johnson & Johnson coronavirus vaccine found to be 66 per cent effective in global trial
SBS
-
Johnson & Johnson’s Covid-19 vaccine results extremely encouraging – experts
Belfast Telegraph
Advertisement
More coverage
Johnson & Johnson Says Its One-Dose Coronavirus Vaccine Was 66% Effective in Clinical Trial
Motley Fool
The vaccine was 100% effective in preventing hospitalization and death from COVID-19.
-
'Game changer' single-dose vaccine from Johnson & Johnson is safe and 66% effective, company says
Upworthy
-
Johnson & Johnson single-shot COVID-19 vaccine appears 66% effective overall in global trial
CBC.ca
-
Covid: Johnson & Johnson's single-dose vaccine 66% effective
Khaleej Times
-
Johnson and Johnson vaccine is 66 percent effective at preventing Covid-19 illness in phase 3 trial
Upworthy